The rising demand for ketamine, mainly for emotional ailments, presents significant challenges regarding the dispensing and discreet delivery within the United States. Stringent national guidelines govern the process, demanding conformity from vendors. Furthermore, preserving customer confidentiality through meticulous transport protocols and compl